Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002625524 | SCV002950412 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003167474 | SCV003865863 | uncertain significance | Inborn genetic diseases | 2023-01-09 | criteria provided, single submitter | clinical testing | The c.3706G>A (p.V1236I) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a G to A substitution at nucleotide position 3706, causing the valine (V) at amino acid position 1236 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV003443064 | SCV004168762 | uncertain significance | not provided | 2023-04-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Mayo Clinic Laboratories, |
RCV003443064 | SCV005410851 | uncertain significance | not provided | 2023-10-19 | criteria provided, single submitter | clinical testing |